Effects of fluvastatin on biliary lipids in subjects with an elevated cholesterol saturation index

European Journal of Clinical Pharmacology

Volumn 56, Issue 12, 2001, Pages 873-879

  Porsch Ozcurumez, Mustafa ^a,b   Hardt, Philip Daniel ^b   Schnell Kretschmer, Henning ^b   Von Bergmann, Klaus ^c   Darui, Cyrill ^b   Nonhoff, Jörg ^b   Abletshauser, Claudia ^d   Klör, Hans Ulrich ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d NOVARTIS PHARMA GMBH   (Germany)

Author keywords

Bile acids; Cholelithiasis; Hydroxymethylglutaryl CoA reductase inhibitors

Indexed keywords

BILE ACID; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDOLE DERIVATIVE; MONOUNSATURATED FATTY ACID;

AGED; ARTICLE; BLOOD; CHOLELITHIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

AGED; BILE ACIDS AND SALTS; CHOLELITHIASIS; DOUBLE-BLIND METHOD; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INDOLES; MALE; MIDDLE AGED;

EID: 0034465227     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280000254     Document Type: Article

References (40)

1. Eriksson M, Angelin B (1987) Bezafibrate therapy and biliary lipids: effects of short-term and long-term treatment in patients with various forms of hyperlipoproteinaemia. Eur J Clin Invest 17:396-401
2. Leiss O, von Bergmann K, Gnasso A, Augustin J (1985) Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects. Metabolism 34:74-82
3. Smit JW, van Erpecum KJ, Stolk MF, Geerdink RA, Cluysenaer OJ, Erkelens DW, van Berge Henegouwen GP (1992) Successful dissolution of cholesterol gallstone during treatment with pravastatin. Gastroenterology 103:1068-1070
4. Okamoto S, Nakano K, Kosahara K, Kishinaka M, Oda H, Ichimiya H, Chijiiwa K, Kuroki S (1994) Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones. J Gastroenterol 29:47-55
5. Smit JW, van Erpecum KJ, Renooij W, Stolk MF, Edgar P, Doornewaard H, Vanberge-Henegouwen GP (1995) The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease. Hepatology 21:1523-1529
6. Smit JW, Van Erpecum KJ, Van Berge-Henegouwen GP (1996) Cholesterol synthesis inhibitors in cholesterol gallstone disease. Scand J Gastroenterol Suppl 218:56-60
7. Duane WC (1994) Effects of lovastatin in humans on biliary lipid composition and secretion as a function of dosage and treatment interval. J Pharmacol Exp Ther 270:841-845
8. Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ (1979) Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 77:611-617
9. De Santis A, Attili AF, Corradini SG, Scafato E, Cantagalli A, De Luca C, Pinto G, Lisi D, Capocaccia L (1997) Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology 25:787-790
10. Peters TK (1996) Safety profile of fluvastatin. Br J Clin Pract Suppl 77A:20-23
11. Tazuma S, Ohya T, Mizuno T, Takizawa I, Kunita T, Takata K, Hayashi K, Hino F, Tokumo H, Watanabe T, et al (1995) Effects of fluvastatin on human biliary lipids. Am J Cardiol 76:110A-113A
12. Lewis B (1988) Population and individual strategies for the prevention of coronary heart disease. Policy of the European Atherosclerosis Society. Drugs 36[Suppl 3]:95-99
13. Admirand WH, Small DM (1968) The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 47:1043-1052
14. Kuroki S, Cohen BI, Carey MC, Mosbach EH (1986) Rapid computation with the personal computer of the percent cholesterol saturation of bile samples. J Lipid Res 27:442-446
15. von Bergmann K, Epple-Gutsfeld M, Leiss O (1984) Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology 87:136-143
16. Heinemann T, Axtmann G, von-Bergmann K (1993) Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest 23:827-831
17. Bjorkhem I, Miettinen T, Reihner E, Ewerth S, Angelin B, Einarsson K (1987) Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res 28:1137-1143
18. National Institutes of Health. Manual of laboratory operations, vol. 1. Lipid Research Clinics Program, Washington, D.C., DHEW (NIH) publication no.75-628, 1974
19. Duane WC, Hunninghake DB, Freeman ML, Pooler PA, Schlasner LA, Gebhard RL (1988) Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile. Hepatology 8:1147-1150
20. Hoogerbrugge van der Linden N, de Rooy FW, Jansen H, van Blankenstein M (1990) Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hypercholesterolaemia. Gut 31:348-350
21. Freeman ML, Prigge WF, Hunninghake DB, Duane WC, Gebhard RL (1988) Intestinal HMG-CoA reductase activity is low in hypercholesterolemic patients and is further decreased with lovastatin therapy. J Lipid Res 29:839-845
22. Miettinen TE, Kiviluoto T, Taavitsainen M, Vuoristo M, Miettinen TA (1998) Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments. Hepatology 27:649-655
23. Miettinen TA, Vanhanen HT, Ojala JP, Tikkanen MJ (1992) Non-cholesterol sterols and faecal elimination of cholesterol during statin and fibrate treatment. Atherosclerosis 97:S73-S80
24. Vanhanen H, Kesaniemi YA, Miettinen TA (1992) Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man. Metabolism 41:588-595
25. Goldberg IJ, Holleran S, Ramakrishnan R, Adams M, Palmer RH, Dell RB, Goodman DS (1990) Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism. J Clin Invest 86:801-808
26. Mitchell JC, Logan GM, Stone BG, Duane WC (1991) Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans. J Lipid Res 32:71-78
27. Ahmed HA, Jazrawi RP, Goggin PM, Dormandy J, Northfield TC (1995) Intrahepatic biliary cholesterol and phospholipid transport in humans: effect of obesity and cholesterol cholelithiasis. J Lipid Res 36:2562-2573
28. Mitchell JC, Stone BG, Logan GM, Dormandy J, Northfield TC (1991) Role of cholesterol synthesis in regulation of bile acid synthesis and biliary cholesterol secretion in humans. J Lipid Res 32:1143-1149
29. Pandak WM, Vlahcevic ZR, Heuman DM, Hylemon PB (1990) Regulation of bile acid synthesis. V. Inhibition of conversion of 7-dehydrocholesterol to cholesterol is associated with down-regulation of cholesterol 7 alpha-hydroxylase activity and inhibition of bile acid synthesis. J Lipid Res 31:2149-2158
30. Stolk MF, van de Heijning BJ, van Erpecum KJ, van den Broek AM, Renooij W, van Berge Henegouwen GP (1994) The effect of bile acid hydrophobicity on nucleation of several types of cholesterol crystals from model bile vesicles. J Hepatol 20:802-810
31. Gallinger S, Taylor RD, Harvey PR, Petrunka CN, Strasberg SM (1985) Effect of mucous glycoprotein on nucleation time of human bile. Gastroenterology 89:648-658
32. O'Leary DP, Murray FE, Turner BS, LaMont JT (1991) Bile salts stimulate glycoprotein release by guinea pig gallbladder in vitro. Hepatology 13:957-961
33. Vanhanen HT, Miettinen TA (1995) Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination. Atherosclerosis 115:135-146
34. Morris JS, Low-Beer TS, Heaton KW (1973) Bile salt metabolism and the colon. Scand J Gastroenterol 8:425-431
35. Low-Beer TS, Nutter S (1978) Colonic bacterial activity, biliary cholesterol saturation, and pathogenesis of gallstones. Lancet 2:1063-1065
36. Thornton JR, Heaton KW (1981) Do colonic bacteria contribute to cholesterol gall-stone formation? Effects of lactulose on bile. BMJ 282:1018-1020
37. Plosker GL, Wagstaff AJ (1996) Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia. Drugs 51:433-459
38. Jokubaitis LA (1996) Fluvastatin in combination with other lipid-lowering agents. Br J Clin Pract Suppl 77A:28-32
39. Attili AF, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L, Capocaccia L, Menotti A, Okolicsanyi L, Ricci G, Lalloni L, Mariotti S, Sama C, Scafato E (1997) Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology 26:809-818
40. Jorgensen T (1989) Gallstones and plasma lipids in a Danish population. Scand J Gastroenterol 24:916-922